Donate

All Posts

In the ‘Advocacy Blog’ Category

Power. Progress. Prevention. January 17, 2020

January 17, 2020 Cancer deaths hit all-time low Between 2016 and 2017, the rate of cancer deaths fell 2.2% — the largest single-year drop in history. While novel treatments and advances in research have contributed to the decline, prevention and early detection played a significant role in many cases—specifically, in lung and cervical cancers. Despite […]

Power. Progress. Prevention. January 3, 2020

January 3, 2020 Trump administration issues partial e-cigarette ban but concerns remain After a long-awaited decision, the Trump administration issued a limited ban on e-cigarettes on Thursday. The ban will remove certain flavors of vaping products from the market; however, menthol and tobacco flavored products are exempt from the ban, and it only applies to flavors […]

Power. Progress. Prevention. December 20, 2019

December 6, 2019 Appeals court declares ACA individual mandate unconstitutional, sends back to lower court On Wednesday, a federal appeals court dealt a blow to the Affordable Care Act (ACA) by striking down its individual mandate provision and ruling it unconstitutional. The mandate, which requires people to purchase and maintain health insurance, was challenged by […]

Power. Progress. Prevention. December 6, 2019

December 6, 2019 Study shows hair dyes and straighteners may pose an increased cancer risk for black women In a study published in the International Journal of Cancer, researchers found that black women who regularly use hair dyes and straighteners may increase their risk of cancer. Results suggested that black women who used permanent hair dyes […]

Power. Progress. Prevention. November 22, 2019

November 22, 2019 White House continues to weigh flavored e-cig ban Last week, reports emerged that the White House was wavering on it proposed policy to ban the sale of flavored e-cigarette products, including mint and menthol flavors. Statements from both presidential advisor Kellyanne Conway and head of the Domestic Policy Council Joe Grogan suggested […]

Power. Progress. Prevention. November 8, 2019

November 8, 2019 Trump administration considers exempting vape shops from e-cigarette ban The president recently announced his intent to ban flavored e-cigarettes from the market to curb the widespread vaping epidemic among children and teens. However, while speaking at the White House on Wednesday, presidential adviser Kellyanne Conway said the administration may exempt vape shops […]

Power. Progress. Prevention. October 25, 2019

October 25, 2019 Save the Date: Prevent Cancer Advocacy Workshop 2020 The Prevent Cancer Advocacy Workshop will be held on March 25, 2020, at the FHI 360 Conference Center in Washington, DC.  The Workshop is an annual event that convenes stakeholders to discuss pressing issues that impact cancer prevention and early detection, as well as novel approaches to […]

Power. Progress. Prevention. September 27, 2019

September 27, 2019 Help Medicare beneficiaries access colorectal cancer screenings The Removing Barriers to Colorectal Cancer Screening Act (H.R. 1570) and its companion bill in the Senate (S. 668) currently have 309 and 59 co-sponsors, respectively. Despite the broad bipartisan support, the bills have stalled in committees. This important legislation would eliminate the coinsurance requirement […]

Power. Progress. Prevention. September 13, 2019

September 13, 2019 Trump administration announces plan to ban flavored electronic cigarettes After six deaths and nearly 500 reported cases of severe lung damage across the country, the Trump administration announced on Wednesday its plan to ban the sale of flavored e-cigarettes, including mint and menthol flavors. Vaping has become increasingly common among teens and […]

Power. Progress. Prevention. August 30, 2019

August 30, 2019 New proposed updates to several screening and vaccination guidelines This week, several updates were issued for screening and vaccination schedules, including recommendations for the human papillomavirus (HPV) vaccine, hepatitis C (hep C) vaccine, and BRCA 1 and 2 genetic testing. The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease […]